Dr. David S. Metsch And Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 542b Turnpike St, North Andover, MA 01845 Phone: 617-448-1758 Fax: 978-685-6641 |
Patti A Richard Dba Family Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 555 Turnpike St, North Andover, MA 01845 Phone: 978-681-1111 |
Dr. Christine Maripuri, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 451 Andover St, North Andover, MA 01845 Phone: 978-688-6182 |
Dr. David Seth Metsch, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 542b Turnpike Street, North Andover, MA 01845 Phone: 978-685-6641 Fax: 978-685-6641 |
Dr. Patti A Richard, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 555 Turnpike St, Suite 56, North Andover, MA 01845 Phone: 978-681-1111 Fax: 978-682-3111 |
Jonathan Pena Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 278 Barker St, North Andover, MA 01845 Phone: 617-356-8117 |
News Archive
The intervention was individualized to each physician's record of action when patient glucose levels were high, and featured regular feedback on their performance.
The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. (Takeda) have partnered to launch the Diabetes Navigator, a compendium capturing a selection of useful and reliable type 2 diabetes information available online for patients and caregivers.
The 2008 earthquake in the Sichuan province of China was among the deadliest in history, killing an estimated 69,000 individuals and leaving millions displaced. Anesthesiologists are critically important medical responders to such disasters, as they have the skills required to resuscitate and stabilize patients while their injuries are surgically treated.
For the past several weeks, various allegations and characterizations have circulated and been reported on regarding FDA's approval and post market review of the drug Vioxx, a "Cox-2 inhibitor," that its sponsor, Merck, voluntarily withdrew from the market September 30th, 2004.
› Verified 4 days ago